Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

CNS Neuroscience and Therapeutics

Volumn 18, Issue 3, 2012, Pages 243-249

  Bowden, C L ^a   Perlis, R H ^b   Thase, M E ^c   Ketter, T A ^d   Ostacher, M M ^d   Calabrese, J R ^e   Reilly Harrington, N A ^b   Gonzalez, J M ^a   Singh, V ^a   Nierenberg, A A ^b   Sachs, G S ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar; Mood disorders; Neuropsychopharmacology; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; INOSITOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; RISPERIDONE; SERTRALINE; VALPROIC ACID;

AFRICAN AMERICAN; ALCOHOLISM; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COGNITIVE THERAPY; COHORT ANALYSIS; DRUG DEPENDENCE; EATING DISORDER; FAMILY THERAPY; GENOMICS; HEALTH PROGRAM; HISPANIC; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MANIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; PROSPECTIVE STUDY; PSYCHOTHERAPY; REMISSION; REVIEW; RISK FACTOR; SLEEP DISORDER; SUBSTANCE ABUSE; SUICIDAL IDEATION; SYSTEMATIC TREATMENT ENHANCEMENT PROGRAM; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UNITED STATES;

EID: 84858281185     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00257.x     Document Type: Review

References (43)

1. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003;53:1028-1042.
2. Sachs GS, Guille C, McMurrich SL. A clinical monitoring form for mood disorders. Bipolar Disorder 2002;4:323-327.
3. Nierenberg AA, Ostacher M, Calabrese J, et al. Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 2006;163:210-216.
4. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1771-1773.
5. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004;161:2222-2229.
6. Ostacher MJ, Perlis RH, Nierenberg AA, et al. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: Prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2010;167:289-297.
7. Nierenberg AA, Miyahara S, Spencer T, et al. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: Data from the first 1000 STEP BD participants. Biol Psychiatry 2005;57:1467-1463.
8. Kogan JN, Otto MW, Bauer MS, et al. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disorder 2004;6:460-469.
9. Simon NM, Otto MW, Weiss RD, et al. Pharmacotherapy for bipolar disorder and cormorbid conditions baseline data from STEP-BD. J Clin Psychopharmacol 2004;24:512-520.
10. Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-224.
11. Judd LL, Akiskal HS, Schettler PJ, et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: A clinical spectrum or distinct disorders? J Affect Disord 2003;73:19-32.
12. Perlis RH, Ostacher MJ, Miklowitz DJ, et al. Benzodiazepine use and risk of recurrence in bipolar disorder: A STEP-BD report. J Clin Psychiatry 2010;71:194-200.
13. Perlis RH, Ostacher MJ, Goldberg JF, et al. Transition to mania during treatment of bipolar depression. Neuropsychopharmacology 2010; 35:2545-2552.
14. Goldberg JF, Perlis RH, Ghaemi SN, et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD. Am J Psychiatry 2007;164:1348-1355.
15. Frye MA, Helleman G, McElroy SL, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 2009;166:164-172.
16. Perlis RH, Ostacher MJ, Uher R, et al. Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disorder 2009;11:867-875.
17. Perlis RH, Ostacher MJ, Miklowitz DJ, et al. Clinical features associated with poor pharmacologic adherence in bipolar disorder: Results from the STEP-BD study. Journal of Clinical Psychiatry 2010;71:296-303.
18. Gruber J, Harvey AG, Wang PW, et al. Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord 2009;114:41-49.
19. Zhang H, Wisniewski SR, Bauer MS, et al. Comparisons of perceived quality of life across clinical states in bipolar disorder: Data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry 2006;47:161-168.
20. Martinez JM, Marangell LB, Simon NM, et al. Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv 2005;56:1541-1548.
21. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. J Am Med Assoc 1990;264:2511-2518.
22. van Zaane J, Van Den BW, Draisma S, et al. The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: A prospective cohort study. J Clin Psychiatry 2010;71:885-893.
23. Weiss RD, Ostacher MJ, Otto MW, et al. Does recovery from substance use disorder matter in patients with bipolar diosrder? J Clin Psychiat 2005;66:730-735.
24. Perlis RH, Dennehy EB, Miklowitz DJ, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: Results from the STEP-BD study. Bipolar Disorder 2009;11:391-400.
25. Ostacher MJ, Lebeau RT, Perlis RH, et al. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disorder 2009;11:766-771.
26. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: Part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv 2006;57:927-936.
27. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv 2006;57:937-945.
28. Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression: A 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry 2007;64:419-426.
29. Miklowitz DJ, Otto MW, Frank E, et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: Results from a 9-month randomized controlled trial. Am J Psychiatry 2007;164:1340-1347.
30. Miklowitz DJ, Otto MW, Wisniewski SR, et al. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. Psychiatr Serv 2006;57:959-965.
31. Gonzalez JM, Thompson P, Escamilla M, et al. Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2, 000 patients of the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull 2007;40:31-46.
32. Gonzalez JM, Bowden CL, Berman N, et al. One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD. Psychiatr Serv 2010;61:164-172.
33. Gonzalez JM, Perlick DA, Miklowitz DJ, et al. Factors associated with stigma among caregivers of patients with bipolar disorder in the STEP-BD study. Psychiatr Serv 2007;58:41-48.
34. Perlick DA, Rosenheck RA, Miklowitz DJ, et al. Caregiver burden and health in bipolar disorder: A cluster analytic approach. J Nerv Ment Dis 2008;196:484-491.
35. Ferreira MA, O'Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008;40:1056-1058.
36. Mansour HA, Talkowski ME, Wood J, et al. Association study of twenty-one circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. under review 2009.
37. Perlis RH, Smoller JW, Ferreira MA, et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009;166:718-725.
38. Parikh SV, LeBlanc SR, Ovanessian MM. Advancing bipolar disorder: Key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Can J Psychiatry 2010;55:136-143.
39. Ghaemi SN, Ostacher MM, El Mallakh RS, et al. Antidepressant discontinuation in bipolar depression: A Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010;71:372-380.
40. Truman CJ, Goldberg JF, Ghaemi SN, et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007;68:1472-1479.
41. Goldberg JF, Perlis RH, Bowden CL, et al. Manic symptoms during depressive episodes in 1, 380 patients with bipolar disorder: Findings from the STEP-BD. Am J Psychiatry 2009;166:173-181.
42. Marangell LB, Dennehy EB, Wisniewski SR, et al. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: Findings from STEP-BD. J Clin Psychiatry 2009;69:916-922.
43. Nowakowska C, Sachs GS, Zarate CA, Jr., et al. Increased rate of non-right-handedness in patients with bipolar disorder. J Clin Psychiatry 2008;69:866-867.